Evidence map›Paper›PMID 40210759›Full record

ArticleOncogene2025

Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer.

Joy C Yang, Pengfei Xu, Shu Ning, Logan J Wasielewski, Hans Adomat, Sung Hee Hwang, Christophe Morisseau, Martin Gleave, Eva Corey, Allen C Gao and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Joy C YangDepartment of Urologic Surgery, University of California Davis, Davis, CA, USA.
Pengfei XuDepartment of Urologic Surgery, University of California Davis, Davis, CA, USA.
Shu NingDepartment of Urologic Surgery, University of California Davis, Davis, CA, USA.
Logan J WasielewskiDepartment of Urologic Surgery, University of California Davis, Davis, CA, USA.
Hans AdomatVancouver Prostate Centre, Vancouver, BC, Canada.
Sung Hee HwangDepartment of Entomology and Nematology, University of California Davis, Davis, CA, USA.
Christophe MorisseauDepartment of Entomology and Nematology, University of California Davis, Davis, CA, USA.
Martin GleaveVancouver Prostate Centre, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0003-4235-0167
Eva CoreyDepartment of Urology, University of Washington, Washington, WA, USA.ORCID http://orcid.org/0000-0002-9244-3807
Allen C GaoDepartment of Urologic Surgery, University of California Davis, Davis, CA, USA.ORCID http://orcid.org/0000-0002-5966-9038
Primo N LaraUC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA.
Christopher P EvansDepartment of Urologic Surgery, University of California Davis, Davis, CA, USA.
Bruce D HammockDepartment of Entomology and Nematology, University of California Davis, Davis, CA, USA.ORCID http://orcid.org/0000-0003-1408-8317
Chengfei LiuDepartment of Urologic Surgery, University of California Davis, Davis, CA, USA. cffliu@ucdavis.edu.ORCID http://orcid.org/0000-0002-2452-8788

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Supplement for bioactive lipids as effectors and indicators of the deleterious effects of human healthR35ES030443 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MORISSEAU, CHRISTOPHE HP · 2019 to 2025
$5.8M
NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R35 ES030443
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40210759
PMCPMC12355828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.